Ali Y. Mansour
C<span style="color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">linical focus includes interventional pulmonary medicine, interstitial lung disease, lung transplantation, vascular medicine and sleep medicine.</span><quillbot-extension-portal></quillbot-extension-portal>
<span style="color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">Dr. Mansour’s research focuses on lung transplant and extracorporeal membrane oxygenation (ECMO) support during critical illnesses from severe lung disease.</span><quillbot-extension-portal></quillbot-extension-portal>
<p style="padding-top:0px;color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">Ali Mansour, MD, is Medical Director, Advanced Pulmonary Failure and Lung Transplantation and Assistant Professor at Montefiore Einstein. His clinical focus includes interventional pulmonary medicine, interstitial lung disease, lung transplantation, vascular medicine and sleep medicine.</p><p style="padding-top:0px;color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">In 2000, Dr. Mansour received his Bachelor of Chemistry at the American University of Beirut. He continued his studies at this institution and received his Doctor of Medicine in 2004. Dr. Mansour began his postgraduate training in 2004 with a yearlong internship at the American University of Beirut Medical College. His training then took him to Kansas, where he completed an internship and residency in internal medicine in 2008 at the Kansas University Medical School. Following this, Dr. Mansour completed a fellowship in pulmonary and critical care that included advanced fellowship training in pulmonary transplantation at Baylor College of Medicine in 2011. In 2012, he completed a sleep fellowship at the University Hospital Case Western Medical Center. Dr. Mansour is board certified in echocardiography and vascular medicine and is accredited as an interventional pulmonologist.</p><p style="padding-top:0px;color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">Dr. Mansour’s research focuses on lung transplant and extracorporeal membrane oxygenation (ECMO) support during critical illnesses from severe lung disease. He is also interested in lung cancer staging and advanced airway procedure to improve and prolong survival. More recently, he supervises numerous clinical studies and trials including novel therapies for SARS-CoV-2. His work has been published in a number of peer-reviewed publications, and he has been an invited speaker to numerous national oral presentations.</p><p style="padding-top:0px;color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">Dr. Mansour is a member of numerous professional societies, including the American Thoracic Society, the American Academy of Sleep Medicine and the American Association for Bronchology and Interventional Pulmonology. He is a fellow of the American College of Chest Physicians.</p>
Michelle Ng Gong
<p>Dr. Gong is the Chief of Critical Care Medicine, Chief of Pulmonary Medicine, and Director of Critical Care Research at Montefiore Medical Center and Professor in Medicine and in Epidemiology and Population Health at Albert Einstein College of Medicine. After receiving an engineering degree at the University of Pennsylvania, Dr. Gong went on to earn a medical degree at the Yale University School of Medicine. She then completed her postdoctoral training at the Beth Israel Hospital in medicine and at the Brigham and Women’s Hospital in the Harvard Combined Program in Pulmonary and Critical Care Medicine. She also studied at the Harvard School of Public Health, receiving her Master’s degree in Clinical Epidemiology. Prior to coming to Albert Einstein College of Medicine and Montefiore Medical Center, she was Assistant Professor of Medicine in the division of Pulmonary, Critical Care and Sleep Medicine at the Mount Sinai School of Medicine. She joined the Einstein/Montefiore faculty in July 2009.</p>
<p>Dr. Gong is recognized nationally and internationally for her expertise in critical care delivery and management of acute respiratory failure and acute respiratory distress syndrome (ARDS). She has spent her career on improving outcomes in patients along the entire continuum of critical illness from its development to its progression and recovery with an overall focus on the prediction and prevention of acute organ failure and their complications. Nationally, she is a well-respected clinical researcher and trialist in acute injury and critical illness. Continuously funded by the NIH for over 20 years for her work, her research ranges from COVID-19 and ARDS to prevention of delirium, treatment of severe influenza, big data and predictive analytics in risk prediction, and effective clinical decision support systems. Her research has been published in the New England Journal of Medicine and JAMA. She has also been funded by the AHRQ on clinical decision making in ARDS and by the NHLBI for the Montefiore-Sinai Clinical Center for the PETAL Clinical Trials Network focused on the prevention and early treatment of ARDS.</p>
<p>A model clinician-researcher, her scientific projects influence her clinical care, and her patients motivates her research. So it is not surprising that some of her proudest achievements have occurred within her clinical work to improve outcomes for patients within Montefiore. This has included process improvement projects such as the implementation of sedation and delirium protocols and early mobilization in the medical intensive care unit that has reduced duration of mechanical ventilation, length of stay, hospital costs and ICU complications. She has also worked on the incorporation of artificial intelligence to help identify patients at increased risk of poor outcomes at Montefiore and evaluation of clinical decision support systems. She has co-authored the Surviving Sepsis Guidelines on management of patients with COVID-19, published in Intensive Care Medicine. </p>
<p>Dr. Gong is a well-regarded leader in the field of pulmonary and critical care medicine. She is a graduate of the prestigious Executive Leadership in Academic Medicine Fellowship and was the former or current chair of the Critical Care Planning Committee and the Critical Care Assembly for the American Thoracic Society. She is also on the Discovery Oversight Committee that helps plan the direction and agenda for the clinical trials initiative of the Society of Critical Care Medicine. Dr. Gong was awarded the Gotham Icon Award for Champions and Change Makers of New York City by the Museum of the City of New York in 2020. Given her expertise, she has been named to multiple panels to develop clinical practice guidelines, including the American College of Chest Physicians and the American Thoracic Society clinical practice guidelines for liberation from mechanical ventilation and the Surviving Sepsis Campaign guidelines for management of severe COVID-19 in 2020. In these leadership positions, she has had the fortune and privilege to mentor residents, fellows and junior investigators both within and beyond Montefiore into productive, academic careers in medicine.</p>
Dr. Gong’s clinical focus is on critical care delivery, predictive analytics, and process improvements, such as the implementation of sedation and delirium protocols and early mobilization in the medical intensive care unit, which has reduced the duration of mechanical ventilation, length of stay, hospital costs, and ICU complications.
Current research ranges from acute respiratory distress syndrome to prevention of delirium, treatment of severe influenza, big data and predictive analysis in risk prediction, and effective clinical decision support systems.
<p>Michelle N. Gong, MD, MS, is a Professor of Medicine and Epidemiology and Population Health at Albert Einstein College of Medicine. She is also the Chief of Critical Care Medicine, Associate Chief of Academic Affairs, and Director of Critical Care Research at Montefiore. Dr. Gong’s clinical focus is on critical care delivery, predictive analytics, and process improvements, such as the implementation of sedation and delirium protocols and early mobilization in the medical intensive care unit, which has reduced the duration of mechanical ventilation, length of stay, hospital costs, and ICU complications. She joined the Einstein/Montefiore faculty in July 2009.</p> <p>Dr. Gong received an Engineering degree at the University of Pennsylvania. She then went on to earn her Doctor of Medicine at the Yale University School of Medicine. She completed her postdoctoral training at the Beth Israel Hospital in medicine and at the Brigham and Women’s Hospital in the Harvard Combined Program in Pulmonary and Critical Care Medicine. Dr. Gong studied at the Harvard School of Public Health, receiving her Master’s Degree in Clinical Epidemiology. </p>Dr. Gong has spent her career improving outcomes in patients along the entire continuum of critical illness, from its development to progression and recovery, with an overall focus on the prediction and prevention of acute organ failure and its complications. Her current research ranges from acute respiratory distress syndrome to prevention of delirium, treatment of severe influenza, big data and predictive analysis in risk prediction, and effective clinical decision support systems. Under her leadership, Montefiore/Einstein was selected as a clinical center for the NHLBI Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Network which represents the first representation of a medical center from the New York and the tri-state area. Collaborating with the research informatics and healthcare industries, Dr. Gong has fostered the application of informatic approaches to drive improvement in healthcare delivery and research.</p><p>In 2013, Dr. Gong received the ATS Innovation in Fellowship Education Award. She is board certified by the American Board of Internal Medicine in Internal Medicine, Critical Care Medicine, Palliative Care Medicine, and Pulmonary Medicine. </p>
Daniel G. Fein
<p><strong>Education</strong></p>
<p>Dr. Daniel Fein completed a medical degree at NYU School of Medicine and an internal medicine residency at Boston University Medical Center. Following residency, he spent five months serving as medical director of the Hillside Health Care Center in Toledo, Belize, and completed fellowship training in pulmonary and critical care at Mount Sinai Beth Israel.</p>
<p><strong>Administrative</strong></p>
<p>Dr. Fein is the director of inpatient pulmonary services for Montefiore Medical Center and the director of the medical and surgical intensive care unit at Montefiore Wakefield where he also serves as the site director for both pulmonary and critical care. Between 2019 and 2022 Dr. Fein served as the web director for the critical care assembly of the American Thoracic Society. </p>
<p><strong>Clinical Specialties</strong></p>
<ul>
<li>Emergency airway management </li>
<li>Ventilator management</li>
<li>Thoracic point of care critical care ultrasound </li>
<li>Chronic obstructive pulmonary disease</li>
</ul>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><strong><span style="font-size: 11pt; color: windowtext;">A. Original Communications in Reviewed Journals</span></strong></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><span style="font-size: 11pt; color: windowtext;">Apter A, Cheng J, Small D, Bennett I, Albert C, <strong>Fein D</strong>, George M, Van Horne S. Asthma Numeracy Skill and Health Literacy. Journal of Asthma 2006;43:705-710. </span></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><span style="font-size: 11pt; color: windowtext;"> </span></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><span style="font-size: 11pt; color: windowtext;">Walkey A, <strong>Fein D</strong>, Horbowicz K, Farber H. Differential Response to Intravenous Prostacyclin Analog Therapy in Patients with Pulmonary Arterial Hypertension. Pulmonary Pharmacology and Therapeutics 2011;24:421-5.</span></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><span style="font-size: 11pt;"> </span></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><span style="font-size: 11pt;">Sampat D, Filopei J, Rao P, <strong>Fein D</strong>, Acquah S. Full circle: Extranodal marginal zone B-cell lymphoma of the trachea. Lung Cancer. 2017 Sep;111:12-14.</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt; font-family: Arial;"> </span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">Hsieh SJ, Otusanya O, Gershengorn HB, Hope AA, Dayton C, Levi D, Garcia M, Prince D, Mills M, <strong>Fein D</strong>, Colman S, Gong MN. Staged Implementation of Awakening and Breathing, Coordination, Delirium Monitoring and Management, and Early Mobilization Bundle Improves Patient Outcomes and Reduces Hospital Costs. Crit Care Med. 2019 Apr;10</span><span style="font-size: 11pt; border: none;"><span style="border: none;">47:885-893.</span></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;"> </span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">Archontakis P, Palaiodimos L, Fleitas Sosa D, Benes L, Gulani P, <strong>Fein D</strong>. Combination of low-dose glucocorticosteroids and mineralocorticoids as adjunct therapy for adult patients with septic shock: A systematic review and meta-analysis of randomized trials and observational studies. </span><span lang="NO-BOK" style="font-size: 11pt;">Avicenna J Med 2019;9:134-42.</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;"> </span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><strong><span style="font-size: 11pt;">Fein DG</span></strong><span style="font-size: 11pt;">, Eisen LA. Video Body Cameras Bridge the Gap Between Simulation and Patient Care During Emergency Airway Management. Chest 2020;158:24-5.</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;"> </span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">Chua A, Murphy C, Hameed S, Weston G, Abramowitz M, Gershengorn H, <strong>Fein DG</strong>. Inferior vena cava filters do not increase the risk of bloodstream infections in patients with newly diagnosed VTE. Am J Infect Control. 2020: 10.1016/j.ajic.2020.05.029. [Epub ahead of print]</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;"> </span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">Kim Y, Dym AA, Yang K, <strong>Fein DG</strong>, et al. The Effect of Numbered Jerseys on Directed Commands, Teamwork, and Clinical Performance During Simulated Emergencies. J Healthc Qual 2021;43:24-31.</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;"> </span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><strong><span style="font-size: 11pt;">Fein DG</span></strong><span style="font-size: 11pt;">, Mastroianni F, Murphy CG, et al. Impact of a Critical Care Specialist Intervention on First Pass Success for Emergency Airway Management Outside the ICU. Journal of Intensive Care Medicine 2021;36:80-8.</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;"> </span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><strong><span style="font-size: 11pt;">Fein DG</span></strong><span style="font-size: 11pt;">, Zhao D, Swartz K, et al. The Impact of Nighttime on First Pass Success During the Emergent Endotracheal Intubation of Critically Ill Patients. Journal of Intensive Care Medicine 2021;36:1498-506.</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-family: Helvetica; border: none;"> </span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">Goligher EC, Bradbury CA, McVerry BJ, et al. (collaborator) Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. The New England Journal of Medicine 2021;385:777-89.</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;"> </span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">Lawler PR, Goligher EC, Berger JS, et al. (collaborator) Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. The New England Journal of Medicine 2021;385:790-802.</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;"> </span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">Keene AB, Shiloh AL, Eisen L, Berger J, Karwa M, <strong>Fein D</strong>, Orsi D, Gong M. </span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">et al. Critical Care Surge During the COVID-19 Pandemic: Implementation and Feedback From Frontline Providers. Journal of Intensive Care Medicine 2021;36:233-40.</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;"> </span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">Russotto V, Myatra SN, Laffey JG, et al. (site principle investigator) Intubation Practices and Adverse Peri-intubation Events in Critically Ill Patients From 29 Countries. JAMA 2021;325:1164-72.</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;"> </span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;">Nauka PC, Chen JT, Shiloh AL, Eisen LA, <strong>Fein DG</strong>. Practice, Outcomes, and Complications of Emergent Endotracheal Intubation by Critical Care Practitioners During the COVID-19 Pandemic. Chest 2021;160:2112-22.</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman';"><span style="font-size: 11pt;"> </span></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><strong><span style="font-size: 11pt;">B. Books, Chapters in Books and Review Articles </span></strong></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><strong><span style="font-size: 11pt;"> </span></strong></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><strong><span style="font-size: 11pt;">Fein D</span></strong><span style="font-size: 11pt;">, Tofts R, Kory P. Thoracic Ultrasound Image Acquisition. Point-of-Care Ultrasound. Soni N, Arntfield R, Kory P. Saunders; 2014. </span></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><span style="font-size: 11pt;"> </span></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><strong><span style="font-size: 11pt;">Fein D</span></strong><span style="font-size: 11pt;">, Verzosa S, Walker P. Cystic Lung Disease. Pulmonary Disease Examination and Board Review. Go R. McGraw Hill; 2016. </span></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><span style="font-size: 11pt;"> </span></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><strong><span style="font-size: 11pt;">Fein D</span></strong><span style="font-size: 11pt;">, Verzosa S, Walker P. Bronchiectasis. Pulmonary Disease Examination and Board Review. Go R. McGraw Hill; 2016.</span></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><span style="font-size: 11pt;"> </span></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><strong><span style="font-size: 11pt; color: windowtext;">Fein DG</span></strong><span style="font-size: 11pt; color: windowtext;">, Zaidi AN, Sulica R. Pulmonary Hypertension Due to Common Respiratory Conditions: Classification, Evaluation and Management Strategies</span><span style="font-size: 11pt;">. Journal of Clinical Medicine 2016;26;5:9. </span></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><span style="font-size: 11pt;"> </span></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><strong><span style="font-size: 11pt;">Fein D</span></strong><span style="font-size: 11pt;">, Abbasi M. Thoracic Ultrasound Image Acquisition. Point-of-Care Ultrasound, second edition. Soni N, Arntfield R, Kory P. Saunders; 2019.</span></p>
<p class="Body" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><span style="font-size: 11pt;"> </span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><span style="font-size: 11pt;">Douglas IS, Bednash JS, <strong>Fein DG</strong>, Mallampalli RK, Mansoori J, Gershengorn HB. Update in Critical Care / ARDS 2018. Am J Respir Crit Care Med. 2019 Jun; 199:1335-1343. </span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><span style="font-size: 11pt;"> </span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><span style="font-size: 11pt;">Islam M, Levitus M, Eisen L, Shiloh AL, <strong>Fein D</strong>. Lung Ultrasound for the Diagnosis and Management of Acute Respiratory Failure. Lung 2020. [Epub ahead of print]</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman'; border: none;"><span style="font-size: 11pt;"> </span></p>
<p>Daniel G. Fein, MD, is Director, Inpatient Pulmonary Services, Director, Pulmonary and Critical Care Medicine, Director, Medical Surgical Intensive Care Unit and Associate Professor, Medicine at Montefiore Einstein. Dr. Fein’s clinical focus centers on emergency airway management, acute respiratory failure, shock and chronic obstructive pulmonary disease.</p><p>After obtaining his Bachelor of Science from Lehigh University in 2002, Dr. Fein earned his Doctor of Medicine at New York University in 2008. He then completed his internal medicine residency at Boston University in 2011, followed by a fellowship in pulmonary and critical care medicine at Mount Sinai Beth Israel in 2015.</p><p>Dr. Fein’s research focus pertains to the practice and management of emergency airway management and acute respiratory failure. He has shared his work through numerous invited presentations, peer-reviewed journals, books, chapters, review articles and abstracts. He has also been a reviewer for scientific journals including the <em>Journal of Clinical Medicine</em>, the <em>Journal of Intensive Care Medicine, CHEST Journal</em> and <em>BMJ Open Access</em>.</p><p>Dr. Fein is board certified by the American Board of Internal Medicine in Pulmonary Disease and Critical Care Medicine. He is a member of the American College of Chest Physicians (ACCP) and the American Thoracic Society (ATS). In 2021, Dr. Fein was recognized as a Leo M. Davidoff Society Honoree. In 2023, he received the Quality Improvement Champion Award from the United Hospital Fund Tribute to Excellence.</p>
Jay B. Dobkin
<p>Clinical Specialty Areas</p>
<ul>
<li>pulmonary function</li>
<li>general pulmonary medicine</li>
</ul>
<p> </p>
Peter V. Dicpinigaitis
<p>Peter Dicpinigaitis, M.D., is a Professor of Medicine at the Albert Einstein College of Medicine, in the Division of Critical Care Medicine. Dr. Dicpinigaitis has been active in the field of cough research for over 25 years. Dr. Dicpinigaitis and colleagues have developed methods of cough reflex sensitivity measurement with the tussive agent capsaicin that have been adopted in international guidelines as the proposed standard method of cough challenge testing.</p>
<p>Using this methodology, Dr. Dicpinigaitis has performed numerous studies to evaluate potential antitussive drugs; to evaluate the effect of non-pharmacological interventions such as cigarette smoking and viral infections on cough reflex sensitivity.</p>
<p>Dr. Dicpinigaitis is founder and director of the Montefiore Cough Center, one of the few specialty centers in the world dedicated to the evaluation and management of patients with chronic cough. He is a co-author of cough management guidelines published by the American College of Chest Physicians and the European Respiratory Society, and is the founder and chairman of the bi-annual American Cough Conference. Dr. Dicpinigaitis also serves as the Editor-in-Chief of the journal <em>LUNG</em>.</p>
<p><strong>Clinical Specialty Areas</strong></p>
<ul>
<li>cough</li>
<li>critical care medicine</li>
</ul>
Mechanisms of cough.
Pathophysiology and treatment of cough.
Founder and director of the Montefiore Cough Center, one of the few specialty centers in the world dedicated to the evaluation and treatment of patients with chronic cough.
Epidemiology, mechanisms and treatment of cough.<br /><quillbot-extension-portal></quillbot-extension-portal>
<ol>
<li>Dicpinigaitis PV, Rhoton WA, Bhat R, Negassa A. Investigation of the urge-to-cough sensation in healthy volunteers. Respirology. 2012;17:337-341.</li>
<li>Dicpinigaitis PV, Weiner FR. Chronic cough associated with interferon/ribavirin therapy for hepatitis C. J Clin Pharm Ther. 2011 Jun;36(3):416-8.</li>
<li>Widdicombe J, Tatar M, Fontana G, Hanacek J, Davenport P, Lavorini F, Bolser D; Other participants. Workshop: tuning the 'cough center'. Pulm Pharmacol Ther. 2011 Jun;24(3):344-52.</li>
<li>Dicpinigaitis PV. Cough: an unmet clinical need. Br J Pharmacol. 2011 May;163(1):116-24. doi: 10.1111/j.1476-5381.2010.01198.x. </li>
<li>Dicpinigaitis PV, Bhat R, Rhoton WA, Tibb AS, Negassa A. Effect of viral upper respiratory tract infection on the urge-to-cough sensation. Respir Med. 2011 Apr;105(4):615-8.</li>
<li>Dicpinigaitis PV. Optimization of tissue oxygenation in critically ill Jehovah's Witness patients. Am J Med. 2010 Aug;123(8):e17; author reply e19.</li>
<li>Sitkauskiene B, Dicpinigaitis PV. Effect of smoking on cough reflex sensitivity in humans. Lung. 2010 Jan;188 Suppl 1:S29-32. </li>
<li>Dicpinigaitis PV. The second american cough conference. Lung. 2010 Jan;188 Suppl 1:S1-2.</li>
<li>Dicpinigaitis PV, Colice GL, Goolsby MJ, Rogg GI, Spector SL, Winther B. Acute cough: a diagnostic and therapeutic challenge. Cough. 2009 Dec 16;5:11.</li>
<li>Bateman ED, Rennard S, Barnes PJ, Dicpinigaitis PV, Gosens R, Gross NJ, Nadel JA, Pfeifer M, Racké K, Rabe KF, Rubin BK, Welte T, Wessler I. Alternative mechanisms for tiotropium. Pulm Pharmacol Ther. 2009 Dec;22(6):533-42. </li>
<li>Dicpinigaitis PV, Sitkauskiene B. Letter to editor regarding Blanc et al, "Capsaicin cough sensitivity in smokers with and without airflow obstruction". Respir Med. 2009 Aug;103(8):1242-3.</li>
<li>Dicpinigaitis PV, Gayle YE, Solomon G, Gilbert RD. Inhibition of cough-reflex sensitivity by benzonatate and guaifenesin in acute viral cough. Respir Med. 2009 Jun;103(6):902-6.</li>
<li>Dicpinigaitis PV. Sex, cough and (digital) audiotape. Thorax. 2009 May;64(5):372-3.</li>
<li>Dicpinigaitis PV. Currently available antitussives. Pulm Pharmacol Ther. 2009 Apr;22(2):148-51. </li>
<li>Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F, Whitten P, Margolis BD, Byrne DW, Ely EW, Rocha MG; SEDCOM (Safety and Efficacy of Dexmedetomidine Compared With Midazolam) Study Group. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA. 2009 Feb 4;301(5):489-99.</li>
<li>Dicpinigaitis PV. Clinical cough III: measuring the cough response in the laboratory. Handb Exp Pharmacol. 2009;(187):297-310. </li>
<li>Stravinskaite K, Sitkauskiene B, Dicpinigaitis PV, Babusyte A, Sakalauskas R. Influence of smoking status on cough reflex sensitivity in subjects with COPD. Lung. 2009 Jan-Feb;187(1):37-42.</li>
<li>Dicpinigaitis PV, Spinner L, Santhyadka G, Negassa A. Effect of tiotropium on cough reflex sensitivity in acute viral cough. Lung. 2008 Nov-Dec;186(6):369-74. </li>
<li>McCool FD. Cough, basic science, and the clinician. Lung. 2008 Mar-Apr;186(2):73-4.</li>
<li>Dicpinigaitis PV. The First American Cough Conference. New York City, June 8-9, 2007. Lung. 2008;186 Suppl 1:S1-2.</li>
<li>Rupp ME, Holley HP Jr, Lutz J, Dicpinigaitis PV, Woods CW, Levine DP, Veney N, Fowler VG Jr. Phase II, randomized, multicenter, double-blind, placebo-controlled trial of a polyclonal anti-Staphylococcus aureus capsular polysaccharide immune globulin in treatment of Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2007 Dec;51(12):4249-54.</li>
<li>Morice AH, Fontana GA, Belvisi MG, Birring SS, Chung KF, Dicpinigaitis PV, Kastelik JA, McGarvey LP, Smith JA, Tatar M, Widdicombe J; European Respiratory Society (ERS). ERS guidelines on the assessment of cough. Eur Respir J. 2007 Jun;29(6):1256-76.</li>
<li>Dicpinigaitis PV. Experimentally induced cough. Pulm Pharmacol Ther. 2007;20(4):319-24. </li>
<li>Sitkauskiene B, Stravinskaite K, Sakalauskas R, Dicpinigaitis PV. Changes in cough reflex sensitivity after cessation and resumption of cigarette smoking. Pulm Pharmacol Ther. 2007;20(3):240-3.</li>
<li>Dicpinigaitis PV, Tso R, Banauch G. Prevalence of depressive symptoms among patients with chronic cough. Chest. 2006 Dec;130(6):1839-43.</li>
<li>Dicpinigaitis PV, Sitkauskiene B, Stravinskaite K, Appel DW, Negassa A, Sakalauskas R. Effect of smoking cessation on cough reflex sensitivity. Eur Respir J. 2006 Oct;28(4):786-90.</li>
<li>Dicpinigaitis PV. Current and future peripherally-acting antitussives. Respir Physiol Neurobiol. 2006 Jul 28;152(3):356-62.</li>
<li>Dicpinigaitis PV. Potential future therapies for the management of cough: ACCP evidence-based clinical practice guidelines. Chest. 2006 Jan;129(1 Suppl):284S-286S. </li>
<li>Dicpinigaitis PV. Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines. Chest. 2006 Jan;129(1 Suppl):169S-173S. </li>
<li>Dicpinigaitis PV. Chronic cough due to asthma: ACCP evidence-based clinical practice guidelines. Chest. 2006 Jan;129(1 Suppl):75S-79S. </li>
<li>Irwin RS, Baumann MH, Bolser DC, Boulet LP, Braman SS, Brightling CE, Brown KK, Canning BJ, Chang AB, Dicpinigaitis PV, Eccles R, Glomb WB, Goldstein LB, Graham LM, Hargreave FE, Kvale PA, Lewis SZ, McCool FD, McCrory DC, Prakash UB, Pratter MR, Rosen MJ, Schulman E, Shannon JJ, Smith Hammond C, Tarlo SM; American College of Chest Physicians (ACCP). Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006 Jan;129(1 Suppl):1S-23S.</li>
<li>Dicpinigaitis PV, Alva RV. Safety of capsaicin cough challenge testing. Chest. 2005 Jul;128(1):196-202. </li>
<li>Morice AH, Fontana GA, Sovijarvi AR, Pistolesi M, Chung KF, Widdicombe J, O'Connell F, Geppetti P, Gronke L, De Jongste J, Belvisi M, Dicpinigaitis P, Fischer A, McGarvey L, Fokkens WJ, Kastelik J; ERS Task Force. The diagnosis and management of chronic cough. Eur Respir J. 2004 Sep;24(3):481-92. PubMed PMID: 15358710.</li>
<li>Dicpinigaitis PV. Potential new cough therapies. Pulm Pharmacol Ther. 2004;17(6):459-62. </li>
<li>Dicpinigaitis PV. Cough. 4: Cough in asthma and eosinophilic bronchitis. Thorax. 2004 Jan;59(1):71-2. </li>
<li>Dicpinigaitis PV, Gayle YE. Effect of guaifenesin on cough reflex sensitivity. Chest. 2003 Dec;124(6):2178-81.</li>
<li>Dicpinigaitis PV, Gayle YE. Effect of the second-generation antihistamine, fexofenadine, on cough reflex sensitivity and pulmonary function. Br J Clin Pharmacol. 2003 Nov;56(5):501-4.</li>
<li>Dicpinigaitis PV. Cough reflex sensitivity in cigarette smokers. Chest. 2003 Mar;123(3):685-8.</li>
<li>Dicpinigaitis PV. Short- and long-term reproducibility of capsaicin cough challenge testing. Pulm Pharmacol Ther. 2003;16(1):61-5.</li>
<li>Dicpinigaitis PV, Dobkin JB, Reichel J. Antitussive effect of the leukotriene receptor antagonist zafirlukast in subjects with cough-variant asthma. J Asthma. 2002 Jun;39(4):291-7.</li>
<li>Morice AH, Widdicombe J, Dicpinigaitis P, Groenke L. Understanding cough. Eur Respir J. 2002 Jan;19(1):6-7.</li>
<li>Dicpinigaitis PV. Capsaicin responsiveness in asthma and COPD. Thorax. 2001 Feb;56(2):162.</li>
<li>Dicpinigaitis PV. Effect of the cyclooxygenase-2 inhibitor celecoxib on bronchial responsiveness and cough reflex sensitivity in asthmatics. Pulm Pharmacol Ther. 2001;14(2):93-7.</li>
<li>Dicpinigaitis PV, Grimm DR, Lesser M. Baclofen-induced cough suppression in cervical spinal cord injury. Arch Phys Med Rehabil. 2000 Jul;81(7):921-3. PubMed PMID: 10896005.</li>
<li>Dicpinigaitis PV, Jones JG, Frymus MM, Folkert VW. "Crack" cocaine-induced syndrome mimicking sarcoidosis. Am J Med Sci. 1999 Jun;317(6):416-8.</li>
<li>Dicpinigaitis PV, Grimm DR, Lesser M. Cough reflex sensitivity in subjects with cervical spinal cord injury. Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1660-2.</li>
<li>Dicpinigaitis PV, Dobkin JB. Effect of zafirlukast on cough reflex sensitivity in asthmatics. J Asthma. 1999 May;36(3):265-70.</li>
<li>Dicpinigaitis PV. Effect of the GABA-agonist baclofen on bronchial responsiveness in asthmatics. Pulm Pharmacol Ther. 1999;12(4):257-60.</li>
<li>Dicpinigaitis PV, Dobkin JB. Effect of angiotensin II receptor blockade on bronchial responsiveness in asthmatic subjects. J Allergy Clin Immunol. 1998 Sep;102(3):521-2.</li>
<li>Dicpinigaitis PV, Dobkin JB, Rauf K, Aldrich TK. Inhibition of capsaicin-induced cough by the gamma-aminobutyric acid agonist baclofen. J Clin Pharmacol. 1998 Apr;38(4):364-7.</li>
<li>Dicpinigaitis PV, Rauf K. Treatment of chronic, refractory cough with baclofen. Respiration. 1998;65(1):86-8.</li>
<li>Dicpinigaitis PV, Dobkin JB. Antitussive effect of the GABA-agonist baclofen. Chest. 1997 Apr;111(4):996-9.</li>
<li>Dicpinigaitis PV, Thomas SA, Sherman MB, Gayle YE, Rosenstreich DL. Losartan-induced bronchospasm. J Allergy Clin Immunol. 1996 Dec;98(6 Pt 1):1128-30.</li>
<li>Dicpinigaitis PV. Use of baclofen to suppress cough induced by angiotensin-converting enzyme inhibitors. Ann Pharmacother. 1996 Nov;30(11):1242-5.</li>
<li>Dicpinigaitis PV, Dobkin JB. Effect of angiotensin-converting enzyme inhibition on bronchial responsiveness. J Clin Pharmacol. 1996 Apr;36(4):361-4.</li>
<li>Dicpinigaitis PV, Mehta DC. Postobstructive pulmonary edema induced by endotracheal tube occlusion. Intensive Care Med. 1995 Dec;21(12):1048-50. PubMed PMID: 8750134.</li>
<li>Dicpinigaitis PV, Levy DE, Gnass RD, Bernstein RG. Pneumonia due to Staphylococcus aureus in a patient with AIDS: review of incidence and report of an atypical roentgenographic presentation. South Med J. 1995 May;88(5):586-90. </li>
<li>Dicpinigaitis PV, Almenoff PL. Effect of pulmonary sympathetic blockade on bronchial responsiveness. Anesthesiology. 1995 Mar;82(3):794-5.</li>
<li>Dicpinigaitis PV, Spungen AM, Bauman WA, Absgarten A, Almenoff PL. Inhibition of bronchial hyperresponsiveness by the GABA-agonist baclofen. Chest. 1994 Sep;106(3):758-61.</li>
<li>Dicpinigaitis PV, Spungen AM, Bauman WA, Absgarten A, Almenoff PL. Bronchial hyperresponsiveness after cervical spinal cord injury. Chest. 1994 Apr;105(4):1073-6.</li>
<li>Dicpinigaitis PV. Acute respiratory distress syndrome. BMJ. 1994 Jan 29;308(6924):344.</li>
<li>Wu LT, Dicpinigaitis P, Bruckner H, Manger W, Averbuch S. Hypertensive crises induced by treatment of malignant pheochromocytoma with a combination of cyclophosphamide, vincristine, and dacarbazine. Med Pediatr Oncol. 1994;22(6):389-92.</li>
<li>Dicpinigaitis PV, Nierman DM, Miller A. Baclofen-induced bronchoconstriction. Ann Pharmacother. 1993 Jul-Aug;27(7-8):883-4.</li>
<li>Spungen AM, Dicpinigaitis PV, Almenoff PL, Bauman WA. Pulmonary obstruction in individuals with cervical spinal cord lesions unmasked by bronchodilator administration. Paraplegia. 1993 Jun;31(6):404-7. </li>
<li>Dicpinigaitis PV, Bleiweiss IJ, Krellenstein DJ, Halton KP, Teirstein AS. Primary endobronchial actinomycosis in association with foreign body aspiration. Chest. 1992 Jan;101(1):283-5. </li>
</ol>
<p>Peter Dicpinigaitis, MD, is a Professor of Medicine at the Albert Einstein College of Medicine, and an attending physician in the Division of Critical Care Medicine at Montefiore Medical Center. In addition to his clinical focus in care of critically ill patients, Dr. Dicpinigaitis is also founder and director of the Montefiore Cough Center, one of the few specialty centers in the world dedicated to the evaluation and treatment of patients with chronic cough.</p><p>A graduate of New York University, Dr. Dicpinigaitis earned his Bachelor of Arts in biochemistry from the institution in 1983 followed by his Doctor of Medicine in 1987. He completed his internship and residency in internal medicine at New York University Medical Center in 1990, followed by his fellowship in pulmonary and critical care medicine at Mount Sinai Medical Center in 1993.</p><p>Dr. Dicpinigaitis’ extensive research focuses on chronic cough, including its mechanisms, manifestations and treatment, and the development of new therapeutic agents. He has more than 100 peer-reviewed publications, and has shared his work through book chapters, abstracts, posters and invited presentations. Dr. Dicpinigaitis is the founder and chairman of the biannual American Cough Conference. He has served on numerous editorial boards and is currently Editor-in-Chief of <em>Lung</em>.</p><p>Dr. Dicpinigaitis is board certified in Internal Medicine, Pulmonary Disease and Critical Care Medicine. He is a Fellow of the American College of Chest Physicians and a member of the American Thoracic Society and the Society of Critical Care Medicine.</p>
Rivkah G. Darabaner
Krystal L. Cleven
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif; background: #fefefe;"><strong><span style="color: #373a3c;">Education:</span></strong></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif; background: #fefefe;"><span style="color: #373a3c;">Dr. Cleven earned her medical degree from SUNY-Downstate College of Medicine. She later completed her Internal Medicine Residency training at the Northwell Health-North Shore/LIJ Hospital and her Pulmonary and Critical Care Medicine Training at Albert Einstein College of Medicine/Montefiore Medical Center.</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif; background: #fefefe;"><strong><span style="color: #373a3c;">Research and Clinical Interests:</span></strong></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif; background: #fefefe;"><span style="color: #373a3c;">Dr. Cleven has a strong research interest in the respiratory health of 9/11 FDNY first responders and has published her research on this topic. She specifically has an interest in post-9/11 sarcoidosis and other respiratory diseases such as asthma. Dr. Cleven is the pulmonary co-director of the Montefiore Asthma Center where she sees patients with severe asthma.</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif; background: #fefefe;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif; background: #fefefe;"><strong><span style="color: #373a3c;">Clinical Interests:</span></strong></p>
<p class="MsoListParagraphCxSpFirst" style="margin: 0in 0in 0.0001pt 0.5in; font-size: 12pt; font-family: Calibri, sans-serif; text-indent: -0.25in;"><span style="color: #373a3c;">1.<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> </span></span><span style="color: #373a3c; background: #fefefe;">Respiratory health of 9/11 first responders</span></p>
<p class="MsoListParagraphCxSpMiddle" style="margin: 0in 0in 0.0001pt 0.5in; font-size: 12pt; font-family: Calibri, sans-serif; text-indent: -0.25in;"><span style="color: #373a3c;">2.<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> </span></span><span style="color: #373a3c; background: #fefefe;">Asthma </span></p>
<p class="MsoListParagraphCxSpMiddle" style="margin: 0in 0in 0.0001pt 0.5in; font-size: 12pt; font-family: Calibri, sans-serif; text-indent: -0.25in;"><span style="color: #373a3c;">3.<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> </span></span><span style="color: #373a3c; background: #fefefe;">Environmental and Occupational Health</span></p>
<p class="MsoListParagraphCxSpLast" style="margin: 0in 0in 0.0001pt 0.5in; font-size: 12pt; font-family: Calibri, sans-serif; text-indent: -0.25in;"><span style="color: #373a3c;">4.<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> </span></span><span style="color: #373a3c; background: #fefefe;">Sarcoidosis</span><span style="color: #373a3c;"> </span></p>
<p class="MsoListParagraphCxSpLast" style="margin: 0in 0in 0.0001pt 0.5in; font-size: 12pt; font-family: Calibri, sans-serif; text-indent: -0.25in;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif; background: #fefefe;"><strong><span style="color: #373a3c;">Board Certification:</span></strong></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif; background: #fefefe;"><span style="color: #373a3c;">Dr. Cleven is board-certified in Internal Medicine and Pulmonary and Critical Care Medicine</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;">Cohen HW, Zeig-Owens R, Joe C, Hall CB, Webber MP, Weiden MD, <strong>Cleven KL</strong>, Jaber N, Skerker M, Yip J, Schwartz T, Prezant DJ. <a style="color: #954f72;" href="https://pubmed.ncbi.nlm.nih.gov/31490535/">Long-term Cardiovascular Disease Risk Among Firefighters After the World Trade Center Disaster</a>. JAMA Netw Open. 2019 Sep 4;2(9):e199775. doi: 10.1001/jamanetworkopen.2019.9775.PMID: 31490535</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Cleven KL</strong>, Ye K, Zeig-Owens R, Hena KM, Montagna C, Shan J, Hosgood HD 3rd, Jaber N, Weiden MD, Colbeth HL, Goldfarb DG, Spivack SD, Prezant DJ. <a style="color: #954f72;" href="https://pubmed.ncbi.nlm.nih.gov/31126090/">Genetic Variants Associated with FDNY WTC-Related Sarcoidosis</a>. Int J Environ Res Public Health. 2019 May 23;16(10):1830. PMID: 31126090</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;">Dicpinigaitis PV, Enilari O, <strong>Cleven KL</strong>. <a style="color: #954f72;" href="https://pubmed.ncbi.nlm.nih.gov/30445192/">Prevalence of Arnold nerve reflex in subjects with and without chronic cough: Relevance to Cough Hypersensitivity Syndrome</a>. Pulm Pharmacol Ther. 2019 Feb;54:22-24. doi: 10.1016/j.pupt.2018.11.003. Epub 2018 Nov 13.PMID: 30445192</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;">Hena KM, Yip J, Jaber N, Goldfarb D, Fullam K, <strong>Cleven K</strong>, Moir W, Zeig-Owens R, Webber MP, Spevack DM, Judson MA, Maier L, Krumerman A, Aizer A, Spivack SD, Berman J, Aldrich TK, Prezant DJ, FDNY Sarcoidosis Clinical Research Group (Christodoulou V, Hena Z, Plotycia SM, Soghier I, Gritz D, Acuna DS, Weiden MD, Nolan A, Diaz K, Ortiz V, Kelly K). <a style="color: #954f72;" title="Clinical Course of Sarcoidosis in World Trade Center Exposed Firefighters" href="https://www.ncbi.nlm.nih.gov/pubmed/29066387" target="_blank" rel="noopener">Clinical Course of Sarcoidosis in World Trade Center Exposed Firefighters</a>. Chest. 2018 Jan;153(1):114-123. PMID: 29066387</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;">Oks M, <strong>Cleven KL</strong>, Healy L, Wei M, Narasimhan M, Mayo PH, Kohn N, Koenig S. T<a style="color: #954f72;" title="he Safety and Utility of Phenobarbital Use for the Treatment of Severe Alcohol Withdrawal Syndrome in the Medical Intensive Care Unit" href="https://www.ncbi.nlm.nih.gov/pubmed/29925291" target="_blank" rel="noopener">he Safety and Utility of Phenobarbital Use for the Treatment of Severe Alcohol Withdrawal Syndrome in the Medical Intensive Care Unit</a>. Journal of Intensive Care Medicine. 2018 Jan. PMID: 29925291</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;">Chua A, <strong>Cleven KL</strong>, Appel D. <a style="color: #954f72;" title="Chylothorax and Pulmonary Arterial Hypertension after Treatment with Dasatinib: A Case Report." href="http://www.anncaserep.com/full-text/accr-v2-id1408.php" target="_blank" rel="noopener">Chylothorax and Pulmonary Arterial Hypertension after Treatment with Dasatinib: A Case Report</a>. Annals of Clinical Case Reports. 2017 Aug. </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Cleven KL</strong>, Webber MP, Zeig-Owens R, Hena KM, Prezant DJ. <a style="color: #954f72;" title="Airway Disease in Rescue/Recovery Workers: Recent Findings from the World Trade Center Collapse" href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Airway+Disease+in+Rescue%2FRe…; target="_blank" rel="noopener">Airway Disease in Rescue/Recovery Workers: Recent Findings from the World Trade Center Collapse</a>. Current Allergy and Asthma Reports. 2017 Jan;17(1):5. PMID: 28181152</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;">Oks M, <strong>Cleven KL</strong>,Cardenas-Garcia J, Schaub JA, Koenig S, Cohen RI, Mayo PH, Narasimhan M. Chest. <a style="color: #954f72;" title="The effect of point-of-care ultrasonography on imaging studies in the medical ICU: a comparative study." href="https://www.ncbi.nlm.nih.gov/pubmed/?term=he+effect+of+point-of-care+ul…; target="_blank" rel="noopener">The effect of point-of-care ultrasonography on imaging studies in the medical ICU: a comparative study.</a> 2014 Dec;146(6). PMID: 25144593</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;">Mackiewicz KL, Sarinopoulos I, <strong>Cleven KL</strong>, Nitschke JB. Proceedings of the National Academy of Sciences. <a style="color: #954f72;" title="The effect of anticipation and the specificity of sex differences for amygdala and hippocampus function in emotional memory." href="https://www.ncbi.nlm.nih.gov/pubmed/?term=The+effect+of+anticipation+an…; target="_blank" rel="noopener">The effect of anticipation and the specificity of sex differences for amygdala and hippocampus function in emotional memory</a>. 2006 Sep; 103(38): 14200-14205. PMID: 16963565</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Poster Presentations</strong></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;">Simon Spivack, <strong>Krystal Cleven</strong>, Miao Shi, Cristina Montagna, Jidong Shan, Dhruv Patel, Aditi Desai, Jidong Shan, Qian Ye, Kerry Hena, David Goldfarb, Jenn Yip, Rachel Zeig-Owens, Kelly Fullam, Nadia Jabar, Thomas Aldrich, David Prezant. WTC-Associated Sarcoidosis: A pilot genotypic survey. American Thoracic Society. May 2018.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Cleven KL</strong>, Shi M, Aldabagh M, Shan J, Ye Q, Hena K, Goldfarb D, Yip J, Zeig-Owens R, Fullam K, Jabar N, Aldrich T, Prezant D, Spivack S. WTC-Associated Sarcoidosis: A pilot genotypic survey. New York State Thoracic Society. April 2018.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;">Chua A, <strong>Cleven KL</strong>, Appel D. <a style="color: #954f72;" title="Chylothorax and PAH After Treatment with Dasatinib: A Case Report" href="https://journal.chestnet.org/article/S0012-3692(16)56859-7/fulltext?cod…; target="_blank" rel="noopener">Chylothorax and PAH After Treatment with Dasatinib: A Case Report</a>. Chest. 2016</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;">Hena K, Yip J, Jaber N, Goldfarb D, Fullam K, <strong>Cleven KL</strong>, Christodoulou V, Moir W, Hena Z, Crosse T, Zeig-Owens R, Webber M, Plotycia S, Gritz D, Spevack D, Soghier I, Prezant D, Aldrich T. Clinical Characteristics of Sarcoidosis in World Trade Center (WTC) Exposed Fire Department of the City of New York (FDNY) Firefighters. Chest. 2016</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Cleven KL</strong>, Healy L, Wei M, Koenig S, Mayo P, Narasimhan M, Oks M. Safety of Phenobarbital Use for Alcohol Withdrawal Syndrome in the Medical Intensive Care Unit. Chest. 2015</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Cleven KL</strong>, Myers AK. A rare case hypercalcemia: a PTH independent malignancy with a normal PTHrP, and low/normal 1-25 Vitamin D. Endocrine Society Conference. 2013.</p>
Stephanie Barrett
David W. Appel
<p><strong>Clinical Specialty Areas</strong></p>
<ul>
<li>sleep medicine</li>
<li>general pulmonary medicine</li>
</ul>
<p><strong>Current Studies</strong></p>
<ol>
<li>Use of a snoring scale and bedside pharyngeal volume measurements to predict obstructive sleep apnea and cpap pressure to treat it prior to the performance of any sleep studies</li>
<li>Sleep and Cough
<ol type="a">
<li>effect of sleep apnea on awake cough response</li>
<li>effect of treatment of sleep apnea on awake cough response</li>
<li>measurement of cough response during sleep among normals/effect of sleep stage</li>
<li>cough response during sleep among people with sleep apnea</li>
</ol>
</li>
<li>Sleep and Gastroespohageal reflux among people with obstructive sleep apnea</li>
<li>Obstructive sleep apnea and aspiration</li>
<li>Restless Leg Syndrome
<ol type="a">
<li>Restless Leg Syndrome among post-gastric bypass patients</li>
<li>Relation between Restless Leg Syndrome and H. pylori</li>
<li>Relation between Restless Leg Syndrome and use of proton pump inhibitors</li>
</ol>
</li>
<li>Obstructive sleep apnea and anemia of aging. Is hepcidin a factor?</li>
<li>Obstructive sleep apnea and congestive heart failure among African Americans</li>
</ol>
<p> </p>